80 FR 59170 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration

Federal Register Volume 80, Issue 190 (October 1, 2015)

Page Range		59170-59171
FR Document		2015-24903

The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); and on April 30, 2010 (75 FR 22809). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at http:// www.samhsa.gov/workplace.

Federal Register, Volume 80 Issue 190 (Thursday, October 1, 2015)

[Federal Register Volume 80, Number 190 (Thursday, October 1, 2015)]
[Notices]
[Pages 59170-59171]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-24903]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Current List of HHS-Certified Laboratories and Instrumented 
Initial Testing Facilities Which Meet Minimum Standards To Engage in 
Urine Drug Testing for Federal Agencies

AGENCY: Substance Abuse and Mental Health Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) notifies 
federal agencies of the laboratories and Instrumented Initial Testing 
Facilities (IITF) currently certified to meet the standards of the 
Mandatory Guidelines for Federal Workplace Drug Testing Programs 
(Mandatory Guidelines). The Mandatory Guidelines were first published 
in the Federal Register on April 11, 1988 (53 FR 11970), and 
subsequently revised in the Federal Register on June 9, 1994 (59 FR 
29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); 
November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); and 
on April 30, 2010 (75 FR 22809).
    A notice listing all currently HHS-certified laboratories and IITFs 
is published in the Federal Register during the first week of each 
month. If any laboratory or IITF certification is suspended or revoked, 
the laboratory or IITF will be omitted from subsequent lists until such 
time as it is restored to full certification under the Mandatory 
Guidelines.
    If any laboratory or IITF has withdrawn from the HHS National 
Laboratory Certification Program (NLCP) during the past month, it will 
be listed at the end and will be omitted from the monthly listing 
thereafter.
    This notice is also available on the Internet at http://www.samhsa.gov/workplace.

FOR FURTHER INFORMATION CONTACT: Giselle Hersh, Division of Workplace 
Programs, SAMHSA/CSAP, Room 7-1051, One Choke Cherry Road, Rockville, 
Maryland 20857; 240-276-2600 (voice), 240-276-2610 (fax).

SUPPLEMENTARY INFORMATION: The Mandatory Guidelines were initially 
developed in accordance with Executive Order 12564 and section 503 of 
Pub. L. 100-71. The ``Mandatory Guidelines for Federal Workplace Drug 
Testing Programs,'' as amended in the revisions listed above, requires 
strict standards that laboratories and IITFs must meet in order to 
conduct drug and specimen validity tests on urine specimens for federal 
agencies.
    To become certified, an applicant laboratory or IITF must undergo 
three rounds of performance testing plus an on-site inspection. To 
maintain that certification, a laboratory or IITF must participate in a 
quarterly performance testing program plus undergo periodic, on-site 
inspections.
    Laboratories and IITFs in the applicant stage of certification are 
not to be considered as meeting the minimum requirements described in 
the HHS Mandatory Guidelines. A HHS-certified laboratory or IITF must 
have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA), 
which attests that it has met minimum standards.

[[Page 59171]]

    In accordance with the Mandatory Guidelines dated November 25, 2008 
(73 FR 71858), the following HHS-certified laboratories and IITFs meet 
the minimum standards to conduct drug and specimen validity tests on 
urine specimens:

HHS-Certified Instrumented Initial Testing Facilities

Dynacare, 6628 50th Street NW., Edmonton, AB Canada T6B 2N7, 780-784-
1190 (Formerly: Gamma-Dynacare Medical Laboratories)

HHS-Certified Laboratories

ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 14624, 
585-429-2264
Aegis Analytical Laboratories, Inc., 345 Hill Ave., Nashville, TN 
37210, 615-255-2400 (Formerly: Aegis Sciences Corporation, Aegis 
Analytical Laboratories, Inc., Aegis Analytical Laboratories)
Alere Toxicology Services, 1111 Newton St., Gretna, LA 70053, 504-361-
8989/800-433-3823, (Formerly: Kroll Laboratory Specialists, Inc., 
Laboratory Specialists, Inc.)
Alere Toxicology Services, 450 Southlake Blvd., Richmond, VA 23236, 
804-378-9130 (Formerly: Kroll Laboratory Specialists, Inc., Scientific 
Testing Laboratories, Inc.; Kroll Scientific Testing Laboratories, 
Inc.)
Baptist Medical Center-Toxicology Laboratory, 11401 I-30, Little Rock, 
AR 72209-7056, 501-202-2783 (Formerly: Forensic Toxicology Laboratory 
Baptist Medical Center)
Clinical Reference Lab, 8433 Quivira Road, Lenexa, KS 66215-2802, 800-
445-6917
DrugScan, Inc., 200 Precision Road, Suite 200, Horsham, PA 19044, 800-
235-4890
Dynacare *, 245 Pall Mall Street, London, ONT, Canada N6A 1P4, 519-679-
1630 (Formerly: Gamma-Dynacare Medical Laboratories)
---------------------------------------------------------------------------

    * The Standards Council of Canada (SCC) voted to end its 
Laboratory Accreditation Program for Substance Abuse (LAPSA) 
effective May 12, 1998. Laboratories certified through that program 
were accredited to conduct forensic urine drug testing as required 
by U.S. Department of Transportation (DOT) regulations. As of that 
date, the certification of those accredited Canadian laboratories 
will continue under DOT authority. The responsibility for conducting 
quarterly performance testing plus periodic on-site inspections of 
those LAPSA-accredited laboratories was transferred to the U.S. HHS, 
with the HHS' NLCP contractor continuing to have an active role in 
the performance testing and laboratory inspection processes. Other 
Canadian laboratories wishing to be considered for the NLCP may 
apply directly to the NLCP contractor just as U.S. laboratories do. 
Upon finding a Canadian laboratory to be qualified, HHS will 
recommend that DOT certify the laboratory (Federal Register, July 
16, 1996) as meeting the minimum standards of the Mandatory 
Guidelines published in the Federal Register on April 30, 2010 (75 
FR 22809). After receiving DOT certification, the laboratory will be 
included in the monthly list of HHS-certified laboratories and 
participate in the NLCP certification maintenance program.
---------------------------------------------------------------------------

ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655, 
662-236-2609
Fortes Laboratories, Inc., 25749 SW Canyon Creek Road, Suite 600, 
Wilsonville, OR 97070, 503-486-1023
Laboratory Corporation of America Holdings, 7207 N. Gessner Road, 
Houston, TX 77040, 713-856-8288/800-800-2387
Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ 
08869, 908-526-2400/800-437-4986, (Formerly: Roche Biomedical 
Laboratories, Inc.)
Laboratory Corporation of America Holdings, 1904 Alexander Drive, 
Research Triangle Park, NC 27709, 919-572-6900/800-833-3984, (Formerly: 
LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, 
Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical 
Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche 
Group)
Laboratory Corporation of America Holdings, 1120 Main Street, 
Southaven, MS 38671, 866-827-8042/800-233-6339 (Formerly: LabCorp 
Occupational Testing Services, Inc.; MedExpress/National Laboratory 
Center)
LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS 
66219, 13-888-3927/800-873-8845 (Formerly: Quest Diagnostics 
Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division 
of LabOne, Inc.)
MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112, 
651-636-7466/800-832-3244
MetroLab-Legacy Laboratory Services, 1225 NE 2nd Ave., Portland, OR 
97232, 503-413-5295/800-950-5295
Minneapolis Veterans Affairs Medical Center, Forensic Toxicology 
Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612-725-2088
National Toxicology Laboratories, Inc., 1100 California Ave., 
Bakersfield, CA 93304, 661-322-4250/800-350-3515
One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena, 
TX 77504, 888-747-3774 (Formerly: University of Texas Medical Branch, 
Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory)
Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA 
91311, 800-328-6942 (Formerly: Centinela Hospital Airport Toxicology 
Laboratory)
Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane, 
WA 99204, 509-755-8991/800-541-7891x7
Phamatech, Inc., 15175 Innovation Drive, San Diego, CA 92128, 888-635-
5840
Quest Diagnostics Incorporated, 1777 Montreal Circle, Tucker, GA 30084, 
800-729-6432 (Formerly: SmithKline Beecham Clinical Laboratories; 
SmithKline Bio-Science Laboratories)
Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403, 
610-631-4600/877-642-2216 (Formerly: SmithKline Beecham Clinical 
Laboratories; SmithKline Bio-Science Laboratories)
Quest Diagnostics Incorporated, 8401 Fallbrook Ave., West Hills, CA 
91304, 818-737-6370 (Formerly: SmithKline Beecham Clinical 
Laboratories)
Redwood Toxicology Laboratory, 3700650 Westwind Blvd., Santa Rosa, CA 
95403, 800-255-2159
Southwest Laboratories, 4625 E. Cotton Center Boulevard, Suite 177, 
Phoenix, AZ 85040, 602-438-8507/800-279-0027
STERLING Reference Laboratories, 2617 East L Street, Tacoma, Washington 
98421, 800-442-0438
US Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., 
Fort George G. Meade, MD 20755-5235, 301-677-7085

Janine Denis Cook,
Chemist, Division of Workplace Programs, Center for Substance Abuse 
Prevention, SAMHSA.
[FR Doc. 2015-24903 Filed 9-30-15; 8:45 am]
BILLING CODE 4160-20-P

59170 Federal Register / Vol. 80, No. 190 / Thursday, October 1, 2015 / Notices

investigator, please indicate your career applications, the disclosure of which (IITF) currently certified to meet the
level and main area of research interest, would constitute a clearly unwarranted standards of the Mandatory Guidelines
including whether the focus is clinical invasion of personal privacy. for Federal Workplace Drug Testing
or basic. If you are a member of a Name of Committee: National Institute of Programs (Mandatory Guidelines). The
particular advocacy or professional Allergy and Infectious Diseases Special Mandatory Guidelines were first
organization, please indicate the name Emphasis Panel; NIAID Peer Review Meeting. published in the Federal Register on
and primary focus of the organization Date: October 23, 2015. April 11, 1988 (53 FR 11970), and
(e.g., research support, patient care, etc.) Time: 10:00 a.m. to 2:00 p.m. subsequently revised in the Federal
and whether you are responding on Agenda: To review and evaluate contract Register on June 9, 1994 (59 FR 29908);
behalf of your organization (if yes, proposals.
Place: National Institutes of Health, Room
September 30, 1997 (62 FR 51118);
please indicate your position within the 3F21A, 5601 Fishers Lane, Rockville, MD April 13, 2004 (69 FR 19644); November
organization). Please provide your name 20892 (Telephone Conference Call). 25, 2008 (73 FR 71858); December 10,
and email address. Contact Person: Maja Maric, Ph.D., 2008 (73 FR 75122); and on April 30,
Privacy Act Notification Statement: Scientific Review Officer Scientific Review 2010 (75 FR 22809).
We are requesting your comments for Program, Division of Extramural Activities, A notice listing all currently HHS-
the 2016–2020 National Institutes of Room # 3F21A National Institutes of Health, certified laboratories and IITFs is
Health Sexual and Gender Minority NIAID, 5601 Fishers Lane, MSC 9823, published in the Federal Register
Strategic Plan. The information you Bethesda, MD 20852, (240) 669–5025,
maja.maric@nih.gov.
during the first week of each month. If
provide may be disclosed to the NIH any laboratory or IITF certification is
Name of Committee: National Institute of
senior staff and those serving on the suspended or revoked, the laboratory or
Allergy and Infectious Diseases Special
SGM Research Coordinating Committee Emphasis Panel; Global Infectious Disease IITF will be omitted from subsequent
and to contractors working on our Research Administration Development lists until such time as it is restored to
behalf. Submission of this information Award for Low- and Middle-Income Country full certification under the Mandatory
is voluntary. However, the information Institutions (G11). Guidelines.
you provide will help to categorize Date: October 28, 2015. If any laboratory or IITF has
responses by scientific area of expertise, Time: 11:00 a.m. to 12:30 p.m. withdrawn from the HHS National
organizational entity or professional Agenda: To review and evaluate grant Laboratory Certification Program (NLCP)
applications.
affiliation. Place: National Institutes of Health Room
during the past month, it will be listed
Collection of this information is 3C100, 5601 Fishers Lane, Rockville, MD at the end and will be omitted from the
authorized under 42 U.S.C. 203, 24 1, 20892 (Telephone Conference Call). monthly listing thereafter.
2891–1 and 44 U.S.C. 310 I and Section Contact Person: Louis A. Rosenthal, Ph.D., This notice is also available on the
30 l and 493 of the Public Health Scientific Review Officer, Scientific Review Internet at http://www.samhsa.gov/
Service Act regarding the establishment Program, Division of Extramural Activities, workplace.
of the National Institutes of Health, its Rm 3G42B, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC–79823, FOR FURTHER INFORMATION CONTACT:
general authority to conduct and fund Giselle Hersh, Division of Workplace
research and to provide training Bethesda, MD 20892–9823, (240) 669–5070,
rosenthalla@niaid.nih.gov. Programs, SAMHSA/CSAP, Room 7–
assistance, and its general authority to 1051, One Choke Cherry Road,
maintain records in connection with (Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology, Rockville, Maryland 20857; 240–276–
these and its other functions. and Transplantation Research; 93.856, 2600 (voice), 240–276–2610 (fax).
Dated: September 24, 2015. Microbiology and Infectious Diseases SUPPLEMENTARY INFORMATION: The
Lawrence A. Tabak, Research, National Institutes of Health, HHS) Mandatory Guidelines were initially
Deputy Director, National Institutes of Health. Dated: September 24, 2015. developed in accordance with Executive
[FR Doc. 2015–25026 Filed 9–30–15; 8:45 am] David Clary, Order 12564 and section 503 of Pub. L.
BILLING CODE 4140–01–P Program Analyst, Office of Federal Advisory 100–71. The ‘‘Mandatory Guidelines for
Committee Policy. Federal Workplace Drug Testing
[FR Doc. 2015–24824 Filed 9–30–15; 8:45 am] Programs,’’ as amended in the revisions
DEPARTMENT OF HEALTH AND BILLING CODE 4140–01–P listed above, requires strict standards
HUMAN SERVICES that laboratories and IITFs must meet in
order to conduct drug and specimen
National Institutes of Health DEPARTMENT OF HEALTH AND validity tests on urine specimens for
HUMAN SERVICES federal agencies.
National Institute of Allergy and
To become certified, an applicant
Infectious Diseases; Notice of Closed Substance Abuse and Mental Health laboratory or IITF must undergo three
Meetings Services Administration rounds of performance testing plus an
Pursuant to section 10(d) of the on-site inspection. To maintain that
Federal Advisory Committee Act, as Current List of HHS-Certified certification, a laboratory or IITF must
amended (5 U.S.C. App.), notice is Laboratories and Instrumented Initial participate in a quarterly performance
hereby given of the following meetings. Testing Facilities Which Meet Minimum testing program plus undergo periodic,
The meetings will be closed to the Standards To Engage in Urine Drug on-site inspections.
public in accordance with the Testing for Federal Agencies Laboratories and IITFs in the
mstockstill on DSK4VPTVN1PROD with NOTICES6

provisions set forth in sections AGENCY: Substance Abuse and Mental applicant stage of certification are not to
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Health Services Administration, HHS. be considered as meeting the minimum
as amended. The grant applications and ACTION: Notice. requirements described in the HHS
the discussions could disclose Mandatory Guidelines. A HHS-certified
confidential trade secrets or commercial SUMMARY: The Department of Health and laboratory or IITF must have its letter of
property such as patentable material, Human Services (HHS) notifies federal certification from HHS/SAMHSA
and personal information concerning agencies of the laboratories and (formerly: HHS/NIDA), which attests
individuals associated with the grant Instrumented Initial Testing Facilities that it has met minimum standards.

VerDate Sep<11>2014 21:04 Sep 30, 2015 Jkt 238001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\01OCN1.SGM 01OCN1

Federal Register / Vol. 80, No. 190 / Thursday, October 1, 2015 / Notices 59171

In accordance with the Mandatory 679–1630 (Formerly: Gamma- 800–328–6942 (Formerly: Centinela
Guidelines dated November 25, 2008 Dynacare Medical Laboratories) Hospital Airport Toxicology
(73 FR 71858), the following HHS- ElSohly Laboratories, Inc., 5 Industrial Laboratory)
certified laboratories and IITFs meet the Park Drive, Oxford, MS 38655, 662– Pathology Associates Medical
minimum standards to conduct drug 236–2609 Laboratories, 110 West Cliff Dr.,
and specimen validity tests on urine Fortes Laboratories, Inc., 25749 SW Spokane, WA 99204, 509–755–8991/
specimens: Canyon Creek Road, Suite 600, 800–541–7891x7
Wilsonville, OR 97070, 503–486–1023 Phamatech, Inc., 15175 Innovation
HHS-Certified Instrumented Initial Laboratory Corporation of America Drive, San Diego, CA 92128, 888–
Testing Facilities Holdings, 7207 N. Gessner Road, 635–5840
Dynacare, 6628 50th Street NW., Houston, TX 77040, 713–856–8288/ Quest Diagnostics Incorporated, 1777
Edmonton, AB Canada T6B 2N7, 780– 800–800–2387 Montreal Circle, Tucker, GA 30084,
784–1190 (Formerly: Gamma- Laboratory Corporation of America 800–729–6432 (Formerly: SmithKline
Dynacare Medical Laboratories) Holdings, 69 First Ave., Raritan, NJ Beecham Clinical Laboratories;
08869, 908–526–2400/800–437–4986, SmithKline Bio-Science Laboratories)
HHS-Certified Laboratories (Formerly: Roche Biomedical Quest Diagnostics Incorporated, 400
ACM Medical Laboratory, Inc., 160 Laboratories, Inc.) Egypt Road, Norristown, PA 19403,
Elmgrove Park, Rochester, NY 14624, Laboratory Corporation of America 610–631–4600/877–642–2216
585–429–2264 Holdings, 1904 Alexander Drive, (Formerly: SmithKline Beecham
Aegis Analytical Laboratories, Inc., 345 Research Triangle Park, NC 27709, Clinical Laboratories; SmithKline Bio-
Hill Ave., Nashville, TN 37210, 615– 919–572–6900/800–833–3984, Science Laboratories)
255–2400 (Formerly: Aegis Sciences (Formerly: LabCorp Occupational Quest Diagnostics Incorporated, 8401
Corporation, Aegis Analytical Testing Services, Inc., CompuChem Fallbrook Ave., West Hills, CA 91304,
Laboratories, Inc., Aegis Analytical Laboratories, Inc.; CompuChem 818–737–6370 (Formerly: SmithKline
Laboratories) Laboratories, Inc., A Subsidiary of Beecham Clinical Laboratories)
Alere Toxicology Services, 1111 Newton Roche Biomedical Laboratory; Roche Redwood Toxicology Laboratory,
St., Gretna, LA 70053, 504–361–8989/ CompuChem Laboratories, Inc., A 3700650 Westwind Blvd., Santa Rosa,
800–433–3823, (Formerly: Kroll Member of the Roche Group) CA 95403, 800–255–2159
Laboratory Specialists, Inc., Laboratory Corporation of America Southwest Laboratories, 4625 E. Cotton
Laboratory Specialists, Inc.) Holdings, 1120 Main Street, Center Boulevard, Suite 177, Phoenix,
Alere Toxicology Services, 450 Southaven, MS 38671, 866–827–8042/ AZ 85040, 602–438–8507/800–279–
Southlake Blvd., Richmond, VA 800–233–6339 (Formerly: LabCorp 0027
23236, 804–378–9130 (Formerly: Occupational Testing Services, Inc.; STERLING Reference Laboratories, 2617
Kroll Laboratory Specialists, Inc., MedExpress/National Laboratory East L Street, Tacoma, Washington
Scientific Testing Laboratories, Inc.; Center) 98421, 800–442–0438
Kroll Scientific Testing Laboratories, LabOne, Inc. d/b/a Quest Diagnostics,
US Army Forensic Toxicology Drug
Inc.) 10101 Renner Blvd., Lenexa, KS
Testing Laboratory, 2490 Wilson St.,
Baptist Medical Center-Toxicology 66219, 13–888–3927/800–873–8845
Fort George G. Meade, MD 20755–
Laboratory, 11401 I–30, Little Rock, (Formerly: Quest Diagnostics
5235, 301–677–7085
AR 72209–7056, 501–202–2783 Incorporated; LabOne, Inc.; Center for
(Formerly: Forensic Toxicology Laboratory Services, a Division of Janine Denis Cook,
Laboratory Baptist Medical Center) LabOne, Inc.) Chemist, Division of Workplace Programs,
Clinical Reference Lab, 8433 Quivira MedTox Laboratories, Inc., 402 W. Center for Substance Abuse Prevention,
Road, Lenexa, KS 66215–2802, 800– County Road D, St. Paul, MN 55112, SAMHSA.
445–6917 651–636–7466/800–832–3244 [FR Doc. 2015–24903 Filed 9–30–15; 8:45 am]
DrugScan, Inc., 200 Precision Road, MetroLab-Legacy Laboratory Services, BILLING CODE 4160–20–P
Suite 200, Horsham, PA 19044, 800– 1225 NE 2nd Ave., Portland, OR
235–4890 97232, 503–413–5295/800–950–5295
Dynacare *, 245 Pall Mall Street, Minneapolis Veterans Affairs Medical DEPARTMENT OF HOMELAND
London, ONT, Canada N6A 1P4, 519– Center, Forensic Toxicology SECURITY
Laboratory, 1 Veterans Drive,
* The Standards Council of Canada (SCC) voted Minneapolis, MN 55417, 612–725– Coast Guard
to end its Laboratory Accreditation Program for 2088
Substance Abuse (LAPSA) effective May 12, 1998. National Toxicology Laboratories, Inc., [Docket No. USCG–2015–0912]
Laboratories certified through that program were
1100 California Ave., Bakersfield, CA
accredited to conduct forensic urine drug testing as Merchant Marine Personnel Advisory
required by U.S. Department of Transportation 93304, 661–322–4250/800–350–3515
One Source Toxicology Laboratory, Inc., Committee
(DOT) regulations. As of that date, the certification
of those accredited Canadian laboratories will 1213 Genoa-Red Bluff, Pasadena, TX AGENCY:Coast Guard, DHS.
continue under DOT authority. The responsibility 77504, 888–747–3774 (Formerly:
for conducting quarterly performance testing plus Notice of Federal Advisory
ACTION:
periodic on-site inspections of those LAPSA- University of Texas Medical Branch, Committee Teleconference Meeting.
accredited laboratories was transferred to the U.S. Clinical Chemistry Division; UTMB
mstockstill on DSK4VPTVN1PROD with NOTICES6

HHS, with the HHS’ NLCP contractor continuing to Pathology-Toxicology Laboratory) SUMMARY: The Merchant Marine
have an active role in the performance testing and Pacific Toxicology Laboratories, 9348
laboratory inspection processes. Other Canadian
Personnel Advisory Committee will
laboratories wishing to be considered for the NLCP
DeSoto Ave., Chatsworth, CA 91311, meet, via teleconference, to discuss Task
may apply directly to the NLCP contractor just as Statement 89, concerning the review
U.S. laboratories do. Upon finding a Canadian Federal Register on April 30, 2010 (75 FR 22809). and update of IMO MSC Circular MSC/
laboratory to be qualified, HHS will recommend After receiving DOT certification, the laboratory
that DOT certify the laboratory (Federal Register, will be included in the monthly list of HHS-
Circ.1014- Guidelines on fatigue
July 16, 1996) as meeting the minimum standards certified laboratories and participate in the NLCP mitigation and management. This
of the Mandatory Guidelines published in the certification maintenance program. meeting will be open to the public.

VerDate Sep<11>2014 21:04 Sep 30, 2015 Jkt 238001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\01OCN1.SGM 01OCN1

Document Created: 2015-12-15 08:40:56
Document Modified: 2015-12-15 08:40:56

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Contact		Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, Room 7-1051, One Choke Cherry Road, Rockville, Maryland 20857; 240-276-2600 (voice), 240-276-2610 (fax).
FR Citation		80 FR 59170

80 FR 59170 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICESSubstance Abuse and Mental Health Services Administration

Federal Register Volume 80, Issue 190 (October 1, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration